Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>
<p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa</it>, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acq...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-05-01
|
Series: | BMC Bioinformatics |
Online Access: | http://www.biomedcentral.com/1471-2105/7/272 |
id |
doaj-dfcf984e276d4a50a7920ca69cfc109f |
---|---|
record_format |
Article |
spelling |
doaj-dfcf984e276d4a50a7920ca69cfc109f2020-11-25T00:37:00ZengBMCBMC Bioinformatics1471-21052006-05-017127210.1186/1471-2105-7-272Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it>Guery BenoitLeBerre RozenneComet Jean-PaulBernot GillesMérieau AnnabelleFilopon DidierPolack BenoitGuespin-Michel Janine<p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa</it>, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in these diseases. In lungs, <it>P. aeruginosa </it>settles in a biofilm mode of growth with the secretion of exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing toxins injection or secretion upon <it>in vivo </it>or <it>in vitro </it>activation signals. As the infection persists most of the bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic modifications without genotype's mutations.</p> <p>Results</p> <p>Using the generalised logical method, we designed a minimal model of the TTSS regulatory network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical framework based on formal methods from computer science allowed a rigorous validation and certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a non inducible strain of <it>P. aeruginosa </it>can stably acquire the capacity to be induced by calcium depletion for the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this epigenetic switch was demonstrated <it>in vivo </it>in an acute pulmonary infection model.</p> <p>Conclusion</p> <p>These results may offer new perspectives for therapeutic strategies to prevent lethal infections by <it>P. aeruginosa </it>by reverting the epigenetic inducibility of type III cytotoxicity.</p> http://www.biomedcentral.com/1471-2105/7/272 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Guery Benoit LeBerre Rozenne Comet Jean-Paul Bernot Gilles Mérieau Annabelle Filopon Didier Polack Benoit Guespin-Michel Janine |
spellingShingle |
Guery Benoit LeBerre Rozenne Comet Jean-Paul Bernot Gilles Mérieau Annabelle Filopon Didier Polack Benoit Guespin-Michel Janine Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it> BMC Bioinformatics |
author_facet |
Guery Benoit LeBerre Rozenne Comet Jean-Paul Bernot Gilles Mérieau Annabelle Filopon Didier Polack Benoit Guespin-Michel Janine |
author_sort |
Guery Benoit |
title |
Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it> |
title_short |
Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it> |
title_full |
Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it> |
title_fullStr |
Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it> |
title_full_unstemmed |
Epigenetic acquisition of inducibility of type III cytotoxicity in <it>P. aeruginosa</it> |
title_sort |
epigenetic acquisition of inducibility of type iii cytotoxicity in <it>p. aeruginosa</it> |
publisher |
BMC |
series |
BMC Bioinformatics |
issn |
1471-2105 |
publishDate |
2006-05-01 |
description |
<p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa</it>, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in these diseases. In lungs, <it>P. aeruginosa </it>settles in a biofilm mode of growth with the secretion of exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing toxins injection or secretion upon <it>in vivo </it>or <it>in vitro </it>activation signals. As the infection persists most of the bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic modifications without genotype's mutations.</p> <p>Results</p> <p>Using the generalised logical method, we designed a minimal model of the TTSS regulatory network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical framework based on formal methods from computer science allowed a rigorous validation and certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a non inducible strain of <it>P. aeruginosa </it>can stably acquire the capacity to be induced by calcium depletion for the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this epigenetic switch was demonstrated <it>in vivo </it>in an acute pulmonary infection model.</p> <p>Conclusion</p> <p>These results may offer new perspectives for therapeutic strategies to prevent lethal infections by <it>P. aeruginosa </it>by reverting the epigenetic inducibility of type III cytotoxicity.</p> |
url |
http://www.biomedcentral.com/1471-2105/7/272 |
work_keys_str_mv |
AT guerybenoit epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT leberrerozenne epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT cometjeanpaul epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT bernotgilles epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT merieauannabelle epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT filopondidier epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT polackbenoit epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait AT guespinmicheljanine epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinitpaeruginosait |
_version_ |
1725303046548750336 |